Lv4
510 积分 2021-12-16 加入
Two genes encoding immune-regulatory molecules (LAG3 and IL7R) confer susceptibility to multiple sclerosis
22天前
已完结
Targeting Th17 cells in autoimmune diseases
30天前
已完结
Efficacy and safety of rocatinlimab for the treatment of moderate-to-severe atopic dermatitis in ROCKET-IGNITE and ROCKET-HORIZON: two global, double-blind, placebo-controlled, randomised phase 3 clinical trials
1个月前
已完结
Depletion of LAG‐3+ T Cells Translated to Pharmacology and Improvement in Psoriasis Disease Activity: A Phase I Randomized Study of mAb GSK2831781
1个月前
已完结
Depletion of LAG‐3+ T Cells Translated to Pharmacology and Improvement in Psoriasis Disease Activity: A Phase I Randomized Study of mAb GSK2831781
1个月前
已完结
Depletion of LAG‐3+ T Cells Translated to Pharmacology and Improvement in Psoriasis Disease Activity: A Phase I Randomized Study of mAb GSK2831781
1个月前
已关闭
Checkpoint-based immunotherapy for autoimmune diseases – Opportunities and challenges
1个月前
已完结
An overview of immune checkpoint therapy in autoimmune diseases
1个月前
已完结
Safety, tolerability, and efficacy of the PD-1 agonist antibody JNJ-67484703 in adults with active rheumatoid arthritis: results of a multicenter, double-blind, placebo-controlled, randomized, multiple-dose phase Ib study
1个月前
已完结
A LAG-3–Specific Agonist Antibody for the Treatment of T Cell–Induced Autoimmune Diseases
1个月前
已完结
皖公网安备34019202002308
